Susquehanna International Group’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Susquehanna International Group’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-112,400	Closed	-$36K	–	10915
2018 Q1	$36K	Sell	112,400 -24,000	-18%	-$35.8K	﹤0.01%	9047
2017 Q4	$225K	Sell	136,400 -67,200	-33%	-$116K	﹤0.01%	8068
2017 Q3	$293K	Sell	203,600 -31,500	-13%	-$44.7K	﹤0.01%	7447
2017 Q2	$381K	Buy	+235,100	New	+$527K	﹤0.01%	7141
2016 Q3	–	Sell	-1,288	Closed	-$32K	–	9424
2016 Q2	$32K	Buy	+1,288	New	+$36.4K	﹤0.01%	8318
2015 Q4	–	Sell	-2,950	Closed	-$144K	–	10327
2015 Q3	$144K	Sell	2,950 -1,288	-30%	-$90K	﹤0.01%	8954
2015 Q2	$292K	Sell	4,238 -1,562	-27%	-$72.3K	﹤0.01%	8584
2015 Q1	$207K	Buy	+5,800	New	+$172K	﹤0.01%	8591
2014 Q2	–	Sell	-1,425	Closed	-$38K	–	10310
2014 Q1	$38K	Buy	+1,425	New	+$36.2K	﹤0.01%	8744

Other funds holding ANTH

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Susquehanna International Group's ANTH Position: Q1 2018 in Review

Susquehanna International Group sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2018, closing a stake of 784,744 shares — an estimated $1.17M sold.

Susquehanna International Group first reported a position in ANTH in Q4 2013 and held it in 15 quarters. The position peaked at $1.72M in Q2 2015. 28 funds tracked by Wall St. Rank hold ANTH as of Q1 2018.

Susquehanna International Group reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Susquehanna International Group sold 784,744 Anthera Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.17M.
Susquehanna International Group first reported a position in Anthera Pharmaceuticals, Inc. in Q4 2013 and held it in 15 quarters.
Susquehanna International Group's Anthera Pharmaceuticals, Inc. position peaked at $1.72M in Q2 2015.
28 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2018.

Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.